# Steve Xu

> Steve Xu is a board-certified dermatologist turned medtech founder who runs Sibel Health, the Chicago company commercializing ICU-grade wearable sensors that now monitor patients in more than 20 countries. A physician-engineer trained at Rice, Harvard, and the London School of Economics, he splits his life between the clinic, the lab at Northwestern's Querrey Simpson Institute for Bioelectronics, and a startup chasing a single line: Better Health Data for All.

- **Role:** Co-founder and CEO at Sibel Health
- **Organizations:** Sibel Health, Northwestern University, Querrey Simpson Institute for Bioelectronics (QSIB)
- **Nationality:** American
- **Education:** BS, Bioengineering (summa cum laude), Rice University, MD (Soros Fellow), Harvard Medical School, MSc, Health Policy (Marshall Scholar), London School of Economics
- **Known for:** Co-founded and leads Sibel Health, deployed in 20+ countries across six continents, Authored 120+ peer-reviewed publications in venues including Nature, Science, PNAS, and the New England Journal of Medicine, Named inventor on 15 pending and granted patents

## Career timeline

- **—** — Earns BS in bioengineering, summa cum laude, from Rice University
- **—** — Completes MD at Harvard Medical School as a Soros Fellow
- **—** — Earns MSc in Health Policy at the London School of Economics as a Marshall Scholar
- **—** — Co-founds Sibel Health, a Northwestern bioelectronics spinout, and becomes CEO
- **2022** — Sibel Health raises $33M to scale its wearable-based remote patient monitoring platform
- **2024** — Sibel awarded major grant to advance maternal monitoring in low- and middle-income countries
- **2025** — Sibel receives FDA clearance for ANNE Maternal, a fully wireless maternal-fetal monitoring platform
- **2025** — Sibel awarded $500,000 FDA Drug Development Tools research grant for an AI-enabled scratch-monitoring wearable
- **2025** — Raises a Series C round; total funding to date exceeds $108M

## Achievements

- Co-founded and leads Sibel Health, deployed in 20+ countries across six continents
- Authored 120+ peer-reviewed publications in venues including Nature, Science, PNAS, and the New England Journal of Medicine
- Named inventor on 15 pending and granted patents
- MIT Technology Review 35 Innovators Under 35
- Secured 6 FDA 510(k) clearances within roughly four years
- Funded as an investigator by the NIH, Gates Foundation, FDA, and DoD
- Medical Director of the Querrey Simpson Institute for Bioelectronics at Northwestern
- Ruth K. Freinkel, MD Professor at Northwestern University
- Led the team behind Sibel's win of the inaugural Spinoff Prize

## Latest updates

- **2025-10** — Sibel Health closed a Series C round, pushing total funding past $108M.
- **2025** — ANNE Maternal received FDA clearance as a fully wireless maternal-fetal monitoring platform.
- **2025** — Sibel won a $500,000 FDA grant to develop an AI-enabled wearable that monitors scratching with high accuracy.

## Links

- Website: https://sibelhealth.com
- LinkedIn: http://www.linkedin.com/in/steve-xu-3a158a16
- Twitter/X: https://twitter.com/Sibel_Health
- Facebook: https://facebook.com/sibelhealth/

---

Profile page: https://yespress.io/steve-xu
Published by YesPress — https://yespress.io
Last updated: 2026-06-04